HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
1- (2- nitro- 1- imidazoly)- 3- (2,3- dimethylaziridino)- 2- propanol
Also Known As:
RSU 1164; RSU 1164, (cis)-isomer; RSU 1164, (trans)-isomer; RSU 1165; RSU-1164; RSU-1165; 1H-Imidazole-1-ethanol, alpha-((2,3-dimethyl-1-aziridinyl)methyl)-2-nitro-
Networked:
6
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Organic Chemicals: 133
Nitro Compounds: 66
Nitroimidazoles: 565
Misonidazole: 539
1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol: 6
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Imidazoles: 150
Nitroimidazoles: 565
Misonidazole: 539
1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol: 6
Related Diseases
1.
Prostatic Neoplasms (Prostate Cancer)
07/01/1989 - "
Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy.
"
07/01/1989 - "
To test this hypothesis, Copenhagen rats bearing established Dunning R-3327 AT-2 prostate cancers were treated with PDT treatment alone (HPD 20 mg./kg. injected IP and then 24 hr. later, the tumor exposed to 630 nm. light at 400 mW/cm.2 for 30 min. [total dose 720 J/cm.2]), RSU-1164 alone (injected IP at a dose of 200 mg./kg.) or with the combination of this PDT treatment plus RSU-1164 given 30 min. before light exposure.
"
2.
Melanoma (Melanoma, Malignant)
01/01/1989 - "
The highest measured value of Ci/Ce was 15 for RSU 1164 in HX118 cells at pH 8.4; this compares with a ratio of 1.5 for HX34 cells at the same pH. These studies indicate that the high levels of uptake of the weakly basic sensitizers into melanotic melanoma in vivo is a cell-mediated phenomenon and may be due to a lower average intracellular pH in the melanotic cells.
"
3.
Neoplasms (Cancer)
07/01/1989 - "
These results demonstrated that this combinational treatment synergistically produces a greater retardation in the growth of the AT-2 tumor than either of the monotherapies of RSU-1164 or PDT alone.
"
07/01/1989 - "
To test this hypothesis, Copenhagen rats bearing established Dunning R-3327 AT-2 prostate cancers were treated with PDT treatment alone (HPD 20 mg./kg. injected IP and then 24 hr. later, the tumor exposed to 630 nm. light at 400 mW/cm.2 for 30 min. [total dose 720 J/cm.2]), RSU-1164 alone (injected IP at a dose of 200 mg./kg.) or with the combination of this PDT treatment plus RSU-1164 given 30 min. before light exposure.
"
04/01/1989 - "
The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
"
07/01/1986 - "
Peak tumor levels of each compound, and tumor/plasma ratios (T/P) were found to be high: T/P RSU-1069 = 3.8, RSU-1164 = 3.7; RSU-1172 = 4.0.
"
04/01/1989 - "
Combining a 1.0 to 2.0 mmol/kg dose of RSU 1164 or RSU 1165 with a range of doses of CCNU increased tumor cell killing by a factor of 1.5-1.6 but did not enhance bone marrow stem cell toxicity.
"
4.
Sarcoma (Soft Tissue Sarcoma)
04/15/1989 - "
Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
"
04/15/1989 - "
Euoxic and hypoxic BP-8 murine sarcoma cells were exposed for up to 3 hours to various concentrations of three nitroimidazole derivatives (misonidazole, Ro 03-8799, RSU-1164) at normal or elevated incubation temperatures.
"
09/01/1990 - "
Administering either misonidazole or RSU 1164 before, or hydralazine after, the chemotherapeutic agents melphalan, cyclophosphamide or the nitrosourea CCNU, increased the extent of cell kill in both the KHT sarcoma and RIF-1 tumour.
"
5.
Experimental Melanoma
01/01/1989 - "
In B16 melanoma these levels corresponded to tumour:plasma ratios of 3.8 for RSU 1069 and 3.7 for RSU 1164.
"
01/01/1989 - "
Cellular uptake of RSU 1069, RSU 1164 and a related compound, RB 7040, was measured in vitro as a function of extracellular pH. Melanotic cells from both B16 melanoma and HX118, a human tumour xenograft, showed substantially greater accumulation of these weakly basic sensitizers than any other cell type examined.
"
07/01/1986 - "
The pharmacokinetics following intraperitoneal injection of three members of this series, RSU-1069, RSU-1164, and RSU-1172 have been studied in C57BL mice bearing B16 melanoma.
"
Related Drugs and Biologics
1.
Alkylating Agents
2.
Misonidazole
3.
Lomustine (CCNU)
4.
1- (2- nitro- 1- imidazoly)- 3- (2,3- dimethylaziridino)- 2- propanol
5.
1- (2- nitro- 1- imidazolyl)- 3- aziridino- 2- propanol
6.
Nitroimidazoles
7.
Melphalan (Alkeran)
8.
Hydralazine (Apresoline)
9.
Cyclophosphamide (Cytoxan)
10.
RSU 1172
Related Therapies and Procedures
1.
Photochemotherapy (Photodynamic Therapy)
2.
Intraperitoneal Injections